JAK2/STAT5 inhibition by nilotinib with ruxolitinib contributes to the elimination of CML CD34+ cells in vitro and in vivo.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Amy Cook Tessa Holyoake Susan Rhodes Ravi Bhatia Anthony D Whetton Heather G Jørgensen Paolo Gallipoli Helen Wheadon |
| Publication date | June 23, 2014 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |